Product Information
HALOPERIDOL 0.5 MG TABLET is a generic product labeled by Method Pharmaceuticals LLC, priced at $0.0857 per EA under NDC 58657090001. Its NADAC has been published 43 times since Dec 10, 2025.
FDA first approved this application on Jan 2, 1987. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.5 mg/1
Manufacturer
Method Pharmaceuticals LLCNDC
58657090001
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
HALOPERIDOLApproval Type
Generic (ANDA)
FDA Application
ANDA071173FDA Approved
1/2/1987
TE Code
AB
On Market Since
6/5/2025
Pharmacological Classes
Price Statistics
The NADAC for HALOPERIDOL 0.5 MG TABLET has been published 43 times since Dec 10, 2025, and over the history we have for it it has declined 24.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0857 per EA |
|---|---|
| All-time high | $0.1236 (May 13, 2026) |
| All-time low | $0.0857 (Sep 23, 2026) |
| 52-week high | $0.1236 |
| 52-week low | $0.0857 |
| Median price | $0.1129 |
| Average price | $0.1115 |
| Largest weekly change | -14.4% (Aug 19, 2026) |
| Weeks tracked | 43 |
| Tracking since | Dec 10, 2025 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Method Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Haloperidol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Typical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of HALOPERIDOL 0.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HALOPERIDOL 0.5 MG TABLET, manufactured by Method Pharmaceuticals LLC, is $0.0857 per EA (NDC 58657090001), effective Sep 30, 2026.
How has the price of HALOPERIDOL 0.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for HALOPERIDOL 0.5 MG TABLET has declined 24.1%. It has been tracked across 43 weekly CMS publications since Dec 10, 2025.
What are the highest and lowest recorded NADAC prices for HALOPERIDOL 0.5 MG TABLET?
Since Dec 10, 2025, the NADAC for HALOPERIDOL 0.5 MG TABLET has ranged from a low of $0.0857 (Sep 23, 2026) to a high of $0.1236 (May 13, 2026), with a median of $0.1129 per EA.
Are there cheaper alternatives to HALOPERIDOL 0.5 MG TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as HALOPERIDOL 0.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures HALOPERIDOL 0.5 MG TABLET?
HALOPERIDOL 0.5 MG TABLET (NDC 58657090001) is labeled by Method Pharmaceuticals LLC, and CMS classifies it as a generic product.